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SchizophreniaAbstract Deaths due to acute coronary insufficiency have been reported during or following elec-
troconvulsive therapy (ECT). Various mechanisms related to ECT related deaths also include cere-
bral, and respiratory complications; however, cardiovascular complication remains the most
common. Here, we describe a 55 year old male with a longstanding psychiatric illness with multiple
antipsychotics under regular follow-up and required repeated ECT therapy to have the disease
symptoms under remission. This time he developed acute onset chest pain immediately post ECT
shock and diagnosed as Acute anterior wall myocardial infarction and was taken up for successful
primary coronary revascularization to left anterior descending (LAD) artery 2 h after the chest pain
onset. He was later discharged in a stable state and advised for continuous psychiatric follow-up.
 2016 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Electroconvulsive therapy (ECT) is a safe and effective treat-
ment for severe mood disorders. Rarely there can be serious
complications, such as postictal agitation, cardiovascular com-
promise, prolonged seizures, and status epilepticus, all of
which are important for the clinician to recognize and treat.1
Cardiac complications are the principal cause of medical com-
plications related to ECT.2 Although they are usually insignif-
icant, a small percentage of these cardiac complications can be
potentially fatal. The variety of cardiac complications of ECT
may be grouped in terms of cardiac ischemia, heart failure, and
arrhythmic complications. Here we report a case of acuteanterior wall myocardial infarction immediately following
ECT which was successfully managed with primary
revascularization.
2. Case report
54 year old male diabetic and a known case of Paranoid
Schizophrenia on regular psychiatric follow-up was referred
as a case of acute coronary syndrome to our centre. He also
had a history of multiple repeated ECT therapy prior to
presentation for the same refractory psychiatric symptoms.
Immediate to the recent post-ECT, he developed acute onset
retrosternal chest discomfort, radiating to both the arms,
severe intensity associated with diaphoresis. On examination,
BP was 110/80 mmHg, PR – 90/min, Spo2 97% and clinically
afebrile. Other systemic and cardiovascular examinations were
within normal limits. ECG at presentation revealed ST eleva-
tion in V2 to V6 leads with CPK MB was 237 U/L and Trop
I being positive. Other laboratory parameters included normalpt Heart
2 A. Hirachan, A. Maskeyrenal function test and total leukocyte counts. Lipid profile
revealed total cholesterol 250 mg/dl, HDL cholesterol
35 mg/dl, and LDL cholesterol 166 mg/dl. He was taken up
for primary PCI which revealed a proximal LAD lesion with
TIMI 0 flow. Balloon dilation followed by stent deployment
was done with 3  28 mm drug eluting stent into the LAD
was done, after which successful TIMI 3 flow was maintained
(Figs. 1 and 2). Later, he was chest pain free and was dis-
charged on dual anti[platelets], statin, ACEI, and beta blockers
and asked to regular cardiology and psychiatric follow-up.Figure 1 Angiogram showing LAD lesion cutoff.
Figure 2 Post PCI to LAD lesion.
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Cardiac complications following ECT may range from
arrhythmic to acute coronary syndromes associated with high
morbidity and mortality. Ischemic complications reported
include both ST segment and non-ST segment elevation
myocardial infarction.3 Arrhythmic complications are by far
the most common. They include minor transient arrhythmias,
such as premature ventricular contractions, but also significant
tachyarrhythmias and bradyarrhythmias, such as atrial flutter,
atrial fibrillation, supraventricular tachycardia, ventricular
tachycardia, new left and right BBBs, 2nd degree AV block,
junctional bradycardia, and asystolic cardiac arrest.4,5
The arrhythmic complications of ECT can be easily under-
stood through the concept of seizure-induced autonomic ner-
vous system activity. During the early phase of the seizure,
parasympathetic activity predominates with a fall in pulse rate
and blood pressure. This is followed by a sympathetically
induced rise in pulse rate and blood pressure. These physiolog-
ical responses can precipitate a variety of cardiac complica-
tions especially in patients with preexisting heart disease.5
Symptomatic myocardial ischemia is rare after ECT, and there
is insufficient evidence to support pharmacologic therapy for
the prevention of post-ECT myocardial ischemia. Our patient
had a long history of type 2 Diabetes mellitus, as well as long
duration of different typical antipsychotics including clozapine
and trifluoperazine which in addition have an adverse effect on
the lipid profile which predisposes to more accelerated athero-
genesis. The acute hemodynamic and autonomic stress associ-
ated with ECT may precipitate an acute coronary syndrome on
the background of diseased atherosclerotic coronaries. There
are substantial variations in hemodynamic sequelae; Takada
and colleagues reported a 25% increase in mean arterial
pressure and a 52% increase in heart rate.6 Preexisting cardiac
disease has been associated with increased complication rates,
although most complications remain minor and the vast
majority of patients can safely complete treatment.7
There are no specific guidelines for the stratification of
cardiac risk before ECT. However, ECT is analogous to a
low-risk procedure as defined in 2007 in the clinical guidelines
issued by the American College of Cardiology and the
American Heart Association (ACC–AHA) for the periopera-
tive care of patients undergoing non cardiac surgery.8 Our
index case developed acute coronary syndrome immediately
following the ECT therapy after which the standard primary
revascularization was done and patient was discharged after
few days in a hemodynamically stable state.
4. Conclusion
Acute myocardial infarction is a rare complication noted post
electroconvulsive therapy. In patients with no active cardiac
conditions (e.g. decompensated congestive heart failure,
unstable angina, significant arrhythmias, and valvular disease)
noninvasive cardiac testing is unnecessary, and practitioners
can proceed with risk-factor modification as appropriate.
However, those with active cardiac conditions need proper
pre operative, non invasive or invasive cardiac evaluation
and necessary management prior to ECT therapy. Our case
had no prior cardiac illness nor had any active cardiacfollowing electroconvulsive therapy in a Schizophrenic patient, The Egypt Heart
Acute myocardial infarction 3condition, though developed an acute coronary syndrome
related to ECT treatment.
References
1. Cristancho MA, Alici Y, Augoustides JG, O’Reardon JP. Uncom-
mon but serious complications associated with electroconvulsive
therapy: recognition and management for the clinician. Curr
Psychiatry Rep 2008;10(6):474–80.
2. Rice EH, Sombrotto LB, Markowitz JC, Leon AC. Cardiovascular
morbidity in high-risk patients during ECT. Am J Psychiatry
1994;151:1637–41.
3. Nuttall GA, Bowersox MR, Douglass SB, et al. Morbidity and
mortality in the use of electroconvulsive therapy. J ECT 2004;20
(4):237–41.Please cite this article in press as: Hirachan A, Maskey A Acute myocardial infarction
J (2016), http://dx.doi.org/10.1016/j.ehj.2016.05.0024. Gerring JP, Shields HM. The identification and management of
patients with a high risk for cardiac arrhythmias during modified
ECT. J Clin Psychiatry 1982;43(4):140–3.
5. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA.
Cardiovascular complications of ECT in depressed patients with
cardiac disease. Am J Psychiatry 1994;151(11):1637–41.
6. Takada JY, Solimene MC, da Luz PL, et al. Assessment of the
cardiovascular effects of electroconvulsive therapy in individuals
older than 50 years. Braz J Med Biol Res 2005;38:13495.
7. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA.
Cardiovascular complications of ECT in depressed patients with
cardiac disease. Am J Psychiatry 1993;150:9049.
8. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007
guidelines on perioperative cardiovascular evaluation and care for
noncardiac surgery. J Am Coll Cardiol 2007;50:1707–32.following electroconvulsive therapy in a Schizophrenic patient, The Egypt Heart
